Back to search

Article

STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer

2024-04-04

Abstract excerpt

Oncogenic mutations in KRAS are among the most common in cancer. Classical models suggest that loss of epithelial characteristics and the acquisition of mesenchymal traits are associated with cancer aggressiveness and therapy resistance. However, the mechanistic link between these phenotypes and mutant KRAS biology remains to be established. Here, we identify STAT3 as a genetic modifier of TGF-beta-induced epithel...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
785606b5-1e5e-59af-add1-2d2d98a5bbcf
DOI
10.7554/elife.92559.2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancerDOI 10.7554/elife.92559.2
Select a neighboring publication to make it the new centre.